General Pulmonary   

Does your approach differ based on the underlying condition - such as ANCA-associated vasculitis, rheumatoid arthritis, or another autoimmune disease?

Do the following guidelines impact your approach? Jones et al., PMID 40679934

Is there a role for booster vaccination and if so, how do you approach the timing when a patient is already on a biologic for immunosuppression?